marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-12-2024
Protara Therapeutics Income Statement 2011-2024 | TARA
Annual Income Statement Protara Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
41.4 M | 40.6 M | 75.8 M | 130 M | 16.8 M | 46.8 M | 42.3 M | 31.5 M | 154 M | 32.2 M | - | - | - |
Shares |
11.3 M | 11.3 M | 11.2 M | 7.23 M | 497 K | 453 K | 432 K | 414 K | 412 K | 76.6 K | - | - | - |
Historical Prices |
3.65 | 3.61 | 6.75 | 24.2 | 16.4 | 90.8 | 76 | 76 | 620 | 416 | - | - | - |
Net Income |
-40.4 M | -66 M | -47.3 M | -34 M | -15 M | -20.7 M | -30 M | -28.5 M | -21.4 M | -3.34 M | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | 2.95 M | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-43.6 M | -67.1 M | -47.5 M | -34.4 M | -7.83 M | -21.4 M | -30.4 M | -28.7 M | -20.9 M | -7.58 M | -7.12 M | -8 M | - |
Interest Expense |
- | - | - | 34 K | - | 207 K | 139 K | -14 K | -651 K | 857 K | 861 K | - | - |
EBITDA |
-43.3 M | -66.8 M | -47.4 M | -34.2 M | -15 M | -21.3 M | -30.2 M | -28.6 M | -20.8 M | -7.55 M | - | - | - |
Operating Expenses |
43.6 M | 67.1 M | 47.5 M | 34.4 M | 15.3 M | 26.1 M | 30.4 M | 28.7 M | 20.9 M | 10.5 M | - | - | - |
General and Administrative Expenses |
18.6 M | 20.7 M | 26.4 M | 22.5 M | 8.82 M | 9.52 M | 8.68 M | 9.84 M | 8.49 M | 4.1 M | - | - | - |
All numbers in USD currency
Quarterly Income Statement Protara Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
22.3 M | 21.2 M | 11.4 M | 11.4 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.3 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 11.2 M | 6.32 M | 5.84 M | 5.56 M | 2.63 M | 2.56 M | 2.56 M | 2.63 M | 19.2 M | 17.8 M | 17.7 M | 17.7 M | 17.6 M | 17.6 M | 17.2 M | 16.6 M | 16.6 M | 16.6 M | 16.6 M | 16.5 M | 16.5 M | 16.5 M | 16.4 M | 16.4 M | 11.4 M | 241 K | 240 K | 240 K | 240 K | 239 K | 231 K | 231 K | - | - | - | - | - | - | - | - |
Net Income |
-11.2 M | -9.51 M | -11.1 M | - | -9.86 M | -11.3 M | -9.04 M | - | -7.69 M | -8.54 M | -10.8 M | - | -10.8 M | -12.8 M | -13.5 M | - | -7.97 M | -7.14 M | -10.1 M | - | -2.35 M | -1.43 M | -1.53 M | - | -4.51 M | -4.88 M | -6.08 M | - | -12.3 M | -5.61 M | -6.5 M | -6.96 M | -7.11 M | -7.9 M | -6.55 M | -6.34 M | -5.38 M | -5.07 M | -4.58 M | 7.23 M | -5.18 M | -2.56 M | -2.83 M | -2.4 M | -2.1 M | -1.55 M | -1.86 M | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.95 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-12.3 M | -10.7 M | -11.9 M | - | -10.7 M | -12.1 M | -9.73 M | - | -7.97 M | -8.7 M | -10.9 M | - | -10.8 M | -12.8 M | -13.6 M | - | -8.06 M | -7.27 M | -10.2 M | - | -2.35 M | -1.43 M | -1.53 M | - | -4.62 M | -5 M | -6.36 M | - | -12.3 M | -5.99 M | -6.48 M | - | -7.17 M | -7.85 M | -6.82 M | - | -5.08 M | -4.98 M | -4.62 M | - | 134 K | -2.51 M | -1.93 M | - | -1.91 M | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | 53 K | 10 K | 115 K | - | 92 K | 126 K | 100 K | - | 2 K | -2 K | 1 K | - | -1 K | 15 K | 192 K | - | -84 K | 332 K | -50 K | - | 13 K | -104 K | 211 K | - | -335 K | -128 K | - | - | -10 K | 29 K | 828 K | - | 171 K | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -11.8 M | - | - | - | -9.66 M | - | -7.8 M | -8.6 M | -10.8 M | - | -10.8 M | -12.7 M | -13.5 M | - | -7.99 M | -7.22 M | -10.1 M | - | -2.25 M | -1.41 M | -1.35 M | - | -4.6 M | -4.97 M | -6.33 M | - | -12.2 M | -5.91 M | -6.44 M | - | -7.08 M | -7.8 M | -6.8 M | - | -5.05 M | -4.96 M | -4.61 M | - | 155 K | -2.5 M | -1.93 M | - | -1.89 M | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
12.3 M | 10.7 M | 11.9 M | - | 10.7 M | 12.1 M | 9.73 M | - | 7.97 M | 8.7 M | 10.9 M | - | 10.8 M | 12.8 M | 13.6 M | - | 8.06 M | 7.27 M | 10.2 M | - | 2.35 M | 1.43 M | 1.53 M | 5.38 M | 4.62 M | 5 M | 6.36 M | 5.59 M | 12.3 M | 5.99 M | 6.48 M | 6.87 M | 7.17 M | 7.85 M | 6.82 M | 6.19 M | 5.08 M | 4.98 M | 4.62 M | 3.27 M | 2.81 M | 2.51 M | 1.93 M | 1.79 M | 1.91 M | 1.55 M | 1.87 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
4.26 M | 4.27 M | 4.1 M | - | 4.48 M | 4.89 M | 4.59 M | - | 4.51 M | 5.62 M | 5.6 M | - | 6.74 M | 6.9 M | 6.54 M | - | 5.27 M | 4.8 M | 7.1 M | - | 1.26 M | 442 K | 450 K | - | 2.27 M | 2.24 M | 2.29 M | - | 1.97 M | 2.1 M | 2.23 M | - | 2.32 M | 2.61 M | 2.47 M | - | 2 M | 1.89 M | 1.99 M | - | 1.04 M | 912 K | 744 K | - | 943 K | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency